Clinical Research

Indian Health Outcomes, Public Health and Economics Research Centre (IHOPE) Read More

Clinical Research

LVPEI has been successfully audited by United States - Food and Drug Administration Agency (US FDA) and European Medicine Agency (EMA) for performing clinical trials.

Dr Sayan Basu,
Director of Research

Kallam Anji Reddy Campus
Network Administrator: T. Charitha
Study Co-Ordinator’s: Vijaya, Ramya, Usha, Kavya, Sindupriya, Haripriya, Tejaswini
Study Optometrists: Swathi, Subba Rao
Contact Numbers (Clinical Research): 040-68102268/2269

Bhubaneswar Campus-Clinical Research
Clinical Research Coordinators: Asit, Mahima, Jyotibrahma, S Das
Study Optometrists: Kartik Jana
Contact Number: 06740 2653261

GMRV Campus-Clinical Research
Clinical Research Coordinator: Sumitra, Aishwarya
Contact Number: 9515263101 / 9182211204

KAR CAMPUS- SPONSOR STUDIES
S.No Name of the project Principal Investigator Supported By Duration CTRI
1Long-term effects of semaglutide on diabetic retinopathy in subjects with type 2 diabetes (FOCUS) Dr.Padmaja KumariNovanordisk2020-2025http://ctri.nic.in
2A Phase Iiib/iv, Multicenter, Open-label, Single-arm Study To Investigate The Efficacy And Safety Of Faricimab (ro6867461) In Patients With Polypoidal Choroidal Vasculopathy Dr.Raja NarayananRoche Products PVT Ltd2024-2025http://ctri.nic.in
3A phase III, multicenter, randomized, double masked, sham-controlled study to investigate the efficacy, safety, pharmacokinetics, and pharmacodynamics of RO7200220 administered intravitreally in patients with Uveitic Macular EdemaDr. Mudit TyagiRoche Products PVT Ltd2024-2025http://ctri.nic.in
4A Prospective, Randomized, Multicenter, Masked, Pivotal Study to Assess the Safety and Effectiveness of BYNOCS DAT (Dichoptic Amblyopia Training) Game in Treating Children with AmblyopiaDr.Sampada KulkarniBYNOCS2024-2025http://ctri.nic.in
5A Phase 1/2a Multi-Center, Dose-Escalation, Dose-Expansion Study to Evaluate the Safety and Efficacy of Eyecyte-RPETM when administered as a Single-dose Subretinal Injection in Subjects with Geographic Atrophy (GA) Secondary to Dry Age-related Macular Degeneration (d-AMD) Dr.Vivek DaveEye Stem2024-2026http://ctri.nic.in
6A Phase 3, Multicenter, Double-Masked, Randomized, Parallel Group Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects with Neovascular Age Related Macular DegenerationDr. Ritesh NarulaPFC Pharma2025-2026http://ctri.nic.in
7Evaluation of a novel Glaucoma Drainage Implant (GORE GDI) in Subjects with Primary Open – Angle GlaucomaDr. Sirisha SenthilW.L Gore & Associates, Inc2025-2026http://ctri.nic.in

INVESTIGATOR INITITATED STUDIES
S.No Name of the project Principal Investigator CTRI/Ethics Committee
1Randomized Controlled Study on the Efficacy of Punctal Cautery in severe Dry Eye disease Dr.Swati Singhhttps://ctri.nic.in
2Intraglandular platelet rich plasma injection in moderate to severe dry eye disease: A placebo-controlled trial Dr.Swati Singhhttps://ctri.nic.in
3Artificial Intelligence enabled referral pathways for early diagnosis of complications arising from diabetes: application to diabetic retinopathy. Dr.Padmaja Kumari Ranihttps://ctri.nic.in
4Prospective comparative study of bleb morphology and surgical outcomes with and without use of Oral Doxycycline in patients undergoing trabeculectomy with mitomycin-C.Dr Rashmi Krishnamurthyhttps://ctri.nic.in
5Safety And Efficacy of Collagenase application In Ocular Burns: A Prospective open- label Academic Randomized Controlled Trial.Dr Sayan Basuhttps://ctri.nic.in
6Corneal Dystrophies Caused by SLC4A11 Mutation: A Promising New Paradigm Shift in Therapy Using an Ophthalmic Nonsteroidal Anti-Inflammatory Eye DropsDr.Muralidhar Ramappahttps://ctri.nic.in/
7Study of visual, optical, and structural parameters in eyes with nanophthalmos -SVOSPBNDr.Srihari SiddharthaLEC-BHR-P-09-23-1103
8Safety and efficacy of 360-degree suture trabeculotomy in open angle glaucoma – A Multi-centric, prospective, non-randomized studyDr.Rashmi KrishnamurthyLEC-BHR-P -04-21-613
9The objective of this study is to compare the long-term safety and efficacy of PAUL ® Glaucoma Implant and Ahmed Implant in patients who are undergoing aqueous shunt implant surgery.Dr. Sirisha SenthilLEC-BHR-P-12-23-1148
10To evaluate ocular surface changes secondary to anti-glaucoma medicationsDr. Gowri PratinyaLEC-BHR-R-02-23-1005

MTC CAMPUS- SPONSOR STUDIES
S.No Name Of The Project Principal Investigator Supported By Duration CTRI
1A Prospective, Randomized, Multicenter, Masked, Pivotal Study to Assess the Safety and Effectiveness of BYNOCS DAT (Dichoptic Amblyopia Training) Game in Treating Children with Amblyopia.Dr.DebasmitaBYNOCS2024-2025http://ctri.nic.in
2A Multicenter, Double-Masked, Randomized, Vehicle-Controlled 12-Month (with a 12-month, Double-Masked Extension) Parallel Comparison of the Safety and Efficacy of 0.1% and 0.2% CBT-001 versus Vehicle, Dosed Twice-Daily, in Patients with Pterygium.Dr. Sujata DasCloud break Therapeutics2024-2026http://ctri.nic.in
3A Phase 2/3 Double-Masked, Randomized, 2-Stage, Multicenter Study of the Efficacy and Safety of OCS-01 Eye Drops in Subjects with Diabetic Macular Edema.Dr. Umesh Chandra BeheraOculis Operations2024-2025http://ctri.nic.in
4A Phase 3, Multicenter, Double-Masked, Randomized, Parallel Group Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects with Neovascular Age Related Macular DegenerationDr. Umesh Chandra BeheraPFC Pharma2025-2026http://ctri.nic.in

INVESTIGATOR INITITATED STUDIES - MTC CAMPUS
S.No Name of the project Principal Investigator CTRI/Ethics Committee
1Identification of diagnostic biomarkers in vitreous/ aqueous fluid of ocular tuberculosis patients. Dr Himansu Sekhar BeheraCTRI/2023/06/053753
2Longitudinal IOP and clinical outcomesin pseudoexfoliation stages and other primary glaucoma after medical treatment versus surgical treatment.Dr Aparna Rao2022-130-BHR-46

GMRV CAMPUS - SPONSOR STUDIES
S.No Name of the Project Principal Investigator Supported By Duration CTRI
1A Prospective, Randomized, Multicenter, Masked, Pivotal Study to Assess the Safety and Effectiveness of BYNOCS DAT (Dichoptic Amblyopia Training) Game in Treating Children with AmblyopiaDr.Virender SachdevaBYNOCS2024-2025http://ctri.nic.in

INVESTIGATOR INITITATED STUDIES - GMRV CAMPUS
S.No Name of the project Principal Investigator CTRI/Ethics Committee
1Functional assessments of pathogenic variants in the nuclear and mitochondrial genome contributing to the pathogenesis of hereditary optic neuropathies Dr Virender SachdevaLEC-BHR-07-22-131
2Identification of diagnostic biomarkers in vitreous/ aqueous fluid of ocular tuberculosis patients.(Ocular TB) Dr. Vishal Sanjay JadhavLEC-BHR-09-24-178
3Subclinical Gliptin-induced bullous pemphigoid in patients on oral gliptins Dr Shilpa TaruniLEC-BHR-02-24-172
4Clinical features, vision, visual function and retinal changes in eyes of Vogt Koyanagi Harada Syndrome after initial resolution of inflammation(VKH) Dr Vishal Sanjay JadhavLEC-BHR-09-24-179